Wilms10T Cells

CAD$1,104.00*

Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10⁶ cells for adherent lines or 5 × 10⁶ cells for suspension lines (refer to the batch CoA for details).

Prices excl. taxes plus shipping costs

cryovial

Product number: 300417

Safety data sheet

Product sheet

Certificate of Analysis (CoA)

Description	The Wilms10T cell line was derived from a primary Wilms tumor sample obtained from a patient with Wilms tumor, a pediatric nephroblastoma. This cell line is characterized by a homozygous deletion of the WT1 gene, leading to a complete loss of WT1 function, a critical gene involved in kidney development and the maintenance of normal renal differentiation. Unlike many other Wilms tumor cell lines, Wilms10T lacks any WT1 protein expression, which is reflective of the severe genetic alterations present in this tumor subtype. Additionally, the Wilms10T cell line exhibits loss of heterozygosity (LOH) in the 11p15 chromosomal region, which includes important genes like IGF2, further contributing to its tumorigenic properties. Wilms10T cells have a stable normal karyotype with no major chromosomal rearrangements apart from the specific deletion of the WT1 region. This cell line has been utilized extensively to study the effects of complete WT1 loss on tumor biology, including its impact on cell proliferation, differentiation, and response to various signaling pathways. The cells retain mesenchymal characteristics, expressing markers such as vimentin, while lacking epithelial markers like cytokeratin, indicative of their stromal origin. Significant research has focused on the signaling pathways active in Wilms10T cells. Proteomic studies have demonstrated that these cells show activation of several receptor tyrosine kinases (RTKs) such as IGF1R, PDGFRβ, and AXL, which are known to drive tumorigenesis. Additionally, downstream signaling pathways, including the MAPK and PI3K/AKT pathways, are activated in Wilms10T cells, contributing to their aggressive tumor phenotype. The comprehensive characterization of Wilms10T makes it a valuable model for investigating the molecular underpinnings of Wilms tumor with complete WT1 loss, as well as for exploring potential therapeutic targets in this aggressive tumor subtype.
Organism	Human
Tissue	Kidney
Disease	Wilms tumor
Applications	In vitro cell culture model and biochemical studies
Synonyms	Wilms10

Age	2 years
Gender	Female
Ethnicity	Caucasian
Morphology	Spindle-shaped
Cell type	Wilms cells
Growth properties	Adherent

Citation	Wilms10T (Cytion catalog number 300417)
Biosafety level	1
NCBI_TaxID	9606
CellosaurusAccession	CVCL_A5SL

Mutational profile	WT1 mutation status: homozygous del WT1 within del11p13. LOH: no in 11p13 but UPD in 11p15. CTNNB1 mutation status: homozygous del TCT, p.DS45, UPD 3p

Culture Medium	MSCGM kit (from Lonza)
Dissociation Reagent	Accutase
Doubling time	46 hours
Subculturing	Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
Seeding density	4 x 10⁴ cells/cm²
Fluid renewal	1 to 2 times per week
Freeze medium	As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Thawing and Culturing Cells	Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
Incubation Atmosphere	37°C, 5% CO₂, humidified atmosphere.
Shipping Conditions	Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
Storage Conditions	For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Sterility	Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Lot Number	Certificate Type	Date	Catalog Number
300417-131025	Certificate of Analysis	05. Dec. 2025	300417
300417-221	Certificate of Analysis	23. May. 2025	300417

Wilms10T Cells

General information

Characteristics

Regulatory Data

Biomolecular Data

Handling

Quality Control & Molecular Analysis

Certificate of Analysis (CoA)